{"id":8352,"date":"2025-07-08T15:39:42","date_gmt":"2025-07-08T13:39:42","guid":{"rendered":"https:\/\/www.drfruehwein.de\/chikungunya-vaccination-chikungunya-fever-dr-fruehwein\/"},"modified":"2025-07-08T15:39:43","modified_gmt":"2025-07-08T13:39:43","slug":"chikungunya-vaccination-chikungunya-fever-dr-fruehwein","status":"publish","type":"page","link":"https:\/\/www.drfruehwein.de\/en\/chikungunya-vaccination-chikungunya-fever-dr-fruehwein\/","title":{"rendered":"Chikungunya vaccination \/ Chikungunya fever – Dr. Fr\u00fchwein"},"content":{"rendered":"

New Chikungunya vaccination
\nnow available<\/p><\/h1><\/div>

<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div>
Appointment travel medical consultation<\/span><\/a><\/div>
<\/div><\/div><\/div>

\"\"<\/p>\n<\/div>

<\/div><\/div><\/div>

The first chikungunya vaccine Ixchiq
\nhas been available for you in our practice since April 2025.<\/p><\/h2><\/div>

We will also be happy to advise you on vaccination against
\nChikungunya in our practice as part of your travel preparations.<\/p>\n<\/div>

<\/div><\/div><\/div>

In our practice in Munich, we usually have all travel medicine vaccines in stock.<\/strong><\/p>\n<\/div>

<\/div><\/div><\/div>

<\/h2><\/div>
<\/div><\/div><\/div>

Chikungunya –
\nDisease and vaccination<\/h2><\/div>
<\/div>
<\/div>
<\/div>

Chikungunya fever is a mosquito-borne viral disease that begins suddenly with a high fever and severe joint pain. The disease is mainly spread by Aedes mosquitoes in tropical and subtropical regions. Chikungunya repeatedly leads to major outbreaks, particularly in tropical regions, as is currently the case in LA Reunion with more than 10,000 cases. In recent years, however, the risk of infection with chikungunya has also increased significantly in the Mediterranean region. <\/p>\n

In addition to fever and joint pain, there is often a skin rash, headache and fatigue. The acute phase lasts about a week, but joint pain can last for months. There is no specific treatment, only symptomatic relief with painkillers and hydration. The disease usually heals without consequences, but can be severe, especially for older people or those with a history of the disease. Two vaccines against chikungunya have now been approved in Germany. <\/p>\n

The vaccination is therefore another building block for safe travel in risk areas for travelers.<\/p>\n<\/div>

<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div>
<\/div>
<\/div>
<\/div>
<\/span><\/div><\/div>
<\/div><\/div><\/div>

We will gladly advise you<\/h2><\/div>

In our practice for rice medicine, we are happy to advise you on vaccination against chikungunya.<\/p>\n<\/div>

<\/div>
<\/div>
<\/div>
Appointment travel medical consultation<\/span><\/a><\/div>
<\/div><\/div><\/div>
<\/span>

CDC - Chikungunya World Map 2019<\/h4><\/div><\/div><\/div>
<\/div><\/div><\/div>
<\/div>
<\/div>
<\/div>

Chikungunya fever<\/h2><\/div>

The disease<\/h3><\/div>
<\/div>
<\/div>
<\/div>

Here you will find common questions and answers about the disease.<\/p>\n<\/div>

<\/i><\/i><\/span>Which vaccines are approved in Germany against chikungunya?<\/span><\/a><\/h4><\/div>
\n

Two vaccines against the chikungunya virus are currently licensed in Germany:<\/p>\n

    \n
  1. Ixchiq\u00ae<\/sup>:<\/strong> This live attenuated vaccine from Valneva was approved by the European Commission on June 28, 2024 for people aged 18 and over. It has been available in Germany since March 2025. <\/li>\n
  2. Vimkunya\u00ae<\/sup>:<\/strong> This adjuvanted virus-like particle (VLP) vaccine from Bavarian Nordic was approved by the European Commission in February 2025 for people aged 12 and over.<\/li>\n<\/ol>\n

    Both vaccines are administered as a single dose and leave high antibody titres in approx. 98% of vaccinated persons, which are somewhat lower in vaccinated persons over 65 years of age.<\/p>\n<\/div><\/div><\/div>

    <\/i><\/i><\/span>Are booster vaccinations necessary?<\/span><\/a><\/h4><\/div>
    \n

    There is currently no recommendation for a booster after vaccination against chikungunya. With the live vaccine, high antibody titres were still detectable in 97% of those vaccinated after 12 months.<\/p>\n<\/div><\/div><\/div>

    <\/i><\/i><\/span>Is the vaccination against Chikungunya covered by my health insurance?<\/span><\/a><\/h4><\/div>
    Reimbursement by health insurance companies, whether statutory or private, cannot be guaranteed.
    \nPlease contact your health insurance company directly.<\/div><\/div><\/div>

    <\/i><\/i><\/span>Who should be vaccinated against chikungunya?<\/span><\/a><\/h4><\/div>
    Vaccination may be advisable for all adult travelers to areas with a risk of contracting chikungunya. Our neighboring country Austria, for example, has also issued a recommendation to this effect. The chikungunya vaccination is recommended there for travelers aged 18 and over to endemic areas and for exposed laboratory personnel. The STIKO in Germany has not yet commented on the use of chikungunya vaccines.<\/div><\/div><\/div>

    <\/i><\/i><\/span>How can I get infected with Chikungunya?<\/span><\/a><\/h4><\/div>
    Infection with chikungunya fever occurs through mosquito bites, especially from:<\/p>\n